The Outlook for Vaccines, Variants and Elusive Herd Immunity - Butler Financial, LTD
How will midterm elections impact the market? - October 28, 2022

Resources

The Outlook for Vaccines, Variants and Elusive Herd Immunity

How do COVID-19 vaccines perform against the delta variant? When is FDA approval expected? And is herd immunity really achievable?

Raymond James Biotechnology Analyst Steve Seedhouse, Ph.D., addresses these questions and more in the latest episode of For What It’s Worth. Hear him discuss the latest data around vaccine effectiveness, the transition from pandemic to possible endemic and how COVID-prompted innovation may open the door for the prevention of other illnesses.

  
Listen to For What It's Worth on Spotify

Recorded August 3, 2021.


Other posts you might like
ButlerFinancial
Start fresh with your financial planning this winter

Family & Lifestyle Review your eligibility for benefits programs and get organized for the year. Winter...

read more
ButlerFinancial
Market forecasts

Markets & Investing December 05, 2022 Drew O’Neil discusses fixed income market conditions and offers...

read more
ButlerFinancial
Weekly market guide

Markets & Investing December 02, 2022 Review the latest portfolio strategy commentary from Mike Gibbs,...

read more